1、White PaperRare Diseases in APAC:The Unmet PotentialPUNEET SINGH,ConsultantRIJUL BHARDWAJ,Associate PrincipalDEVARAJ SUBRAMANIAM,Associate Principal,Consulting ServicesTable of contentsIntroduction 2Rare disease overview 3What is the burden of rare diseases?3How are rare diseases defined?3Rare Disea

2、se Management in APAC 4How mature is the APAC rare disease market?4Healthcare policy 6Government funding and access support 7Initiatives to improve diagnosis and treatment 8APAC Rare Disease Market Sizing 9What is the size of the rare disease market in the APAC region?11Conclusion 11References 12Abo

3、ut the authors 13About IQVIA Asia Pacific 14 |2In our two-part report,IQVIA Asia-Pacific presents an overview of the rare disease landscape in the Asia-Pacific(APAC)region.In Part 1 Rare Diseases in APAC:The Unmet Potential,we examine the burden of rare disease in the APAC region,the level of maturi

4、ty regarding rare disease care delivery in various APAC markets,and the potential size of these markets.In Part 2:Unlocking Solutions for Rare Diseases in APAC,we look at current challenges in rare disease management,potential solutions,and innovations in the rare disease space.We consider a broad s

5、et of countries in the APAC region for our analysis(Figure 1)that can be clustered into groups based on macroeconomic indicators such as Gross Domestic Product per capita and healthcare spend per capita.Globally,the focus on rare diseases has grown considerably over the last few years.Even in the AP

6、AC region,this market is gaining momentum owing to the pronounced disease burden and unique challenges that patients face.Countries in the region have varying degrees of maturity regarding rare disease management,with developed markets having more comprehensive ecosystems for care delivery and middl